Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ)
CNY 8.67
(0.58%)
CNY 8.67
(0.58%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 184.33 Million CNY | 0.54% |
| 2022 | 183.34 Million CNY | 54.37% |
| 2021 | 118.77 Million CNY | 36.8% |
| 2020 | 86.82 Million CNY | -7.68% |
| 2019 | 94.03 Million CNY | 14.38% |
| 2018 | 82.21 Million CNY | 23.59% |
| 2017 | 66.52 Million CNY | 54.04% |
| 2016 | 43.18 Million CNY | -1.47% |
| 2015 | 43.83 Million CNY | 30.91% |
| 2014 | 33.48 Million CNY | -12.2% |
| 2013 | 38.13 Million CNY | -33.41% |
| 2012 | 57.26 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 148.97 Million CNY | -9.76% |
| 2024 Q2 | 165.08 Million CNY | -14.12% |
| 2024 Q1 | 192.22 Million CNY | 4.28% |
| 2023 Q3 | 170.33 Million CNY | -4.45% |
| 2023 Q4 | 184.33 Million CNY | 8.22% |
| 2023 FY | 184.33 Million CNY | 0.54% |
| 2023 Q1 | 210.69 Million CNY | 14.92% |
| 2023 Q2 | 178.26 Million CNY | -15.39% |
| 2022 Q3 | 150.13 Million CNY | -10.17% |
| 2022 Q2 | 167.13 Million CNY | 8.17% |
| 2022 Q1 | 154.51 Million CNY | 30.1% |
| 2022 FY | 183.34 Million CNY | 54.37% |
| 2022 Q4 | 183.34 Million CNY | 22.12% |
| 2021 FY | 118.77 Million CNY | 36.8% |
| 2021 Q4 | 118.77 Million CNY | 29.77% |
| 2021 Q2 | 103.1 Million CNY | 8.89% |
| 2021 Q1 | 94.69 Million CNY | 9.07% |
| 2021 Q3 | 91.52 Million CNY | -11.23% |
| 2020 Q4 | 86.82 Million CNY | 10.78% |
| 2020 FY | 86.82 Million CNY | -7.68% |
| 2020 Q1 | 98.52 Million CNY | 4.77% |
| 2020 Q2 | 83.34 Million CNY | -15.41% |
| 2020 Q3 | 78.37 Million CNY | -5.97% |
| 2019 Q2 | 95.45 Million CNY | 10.98% |
| 2019 FY | 94.03 Million CNY | 14.38% |
| 2019 Q4 | 94.03 Million CNY | 0.96% |
| 2019 Q3 | 93.14 Million CNY | -2.42% |
| 2019 Q1 | 86 Million CNY | 4.61% |
| 2018 Q1 | 70.31 Million CNY | 5.7% |
| 2018 Q2 | 69.16 Million CNY | -1.64% |
| 2018 FY | 82.21 Million CNY | 23.59% |
| 2018 Q3 | 72.39 Million CNY | 4.68% |
| 2018 Q4 | 82.21 Million CNY | 13.56% |
| 2017 Q4 | 66.52 Million CNY | 14.46% |
| 2017 FY | 66.52 Million CNY | 54.04% |
| 2017 Q1 | 52.45 Million CNY | 21.45% |
| 2017 Q2 | 60.83 Million CNY | 15.99% |
| 2017 Q3 | 58.11 Million CNY | -4.47% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 Q4 | 43.18 Million CNY | 0.0% |
| 2016 FY | 43.18 Million CNY | -1.47% |
| 2016 Q2 | 40.9 Million CNY | 0.0% |
| 2015 Q3 | 43.83 Million CNY | 40.04% |
| 2015 Q4 | 43.83 Million CNY | 0.0% |
| 2015 Q2 | 31.29 Million CNY | 0.0% |
| 2015 Q1 | 31.29 Million CNY | -6.52% |
| 2015 FY | 43.83 Million CNY | 30.91% |
| 2014 FY | 33.48 Million CNY | -12.2% |
| 2014 Q4 | 33.48 Million CNY | 0.0% |
| 2014 Q3 | 33.48 Million CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2013 FY | 38.13 Million CNY | -33.41% |
| 2012 FY | 57.26 Million CNY | 0.0% |